Skip to main contentSkip to main content
Updating results

Pharmacology

  • Updated

BEIJING (AP) — Beijing residents are coping with abrupt local lockdowns and sweeping COVID-19 testing requirements as the Chinese capital seeks to prevent a coronavirus outbreak ahead of the Winter Olympics that opens in less than two weeks.

  • Updated

TUESDAY, Jan. 18, 2022 (HealthDay News) -- If you vape and catch COVID-19, you may feel a whole lot worse than people who come down with the virus but don't use electronic cigarettes, researchers say.

  • Updated

FRIDAY, Jan. 7, 2022 (HealthDay News) -- It is the ultimate irony: More COVID-19 treatments exist now than at any other time during the pandemic, but the skyrocketing number of cases from the surging omicron variant might mean they cannot be accessed when needed most.

  • Updated

The antiviral pills aren’t for everyone who gets a positive test. The pills are intended for those with mild or moderate COVID-19 who are more…

  • Updated

Merck’s molnupiravir is not authorized for children because it might interfere with bone growth. It also isn't recommended for pregnant women …

  • Updated

Yes, but they aren't as easy to use as a pill: They are given by IV or injection, typically at a hospital or clinic. Three drugs provide virus…

Gov. Pete Ricketts said he had heard anecdotal stories that some doctors are reluctant to prescribe the treatment to people who could benefit from it. "It is incredibly frustrating to me that doctors would do that." 

  • Updated

THURSDAY, Dec. 23, 2021 (HealthDay News) -- Many Americans now have two oral antiviral pills that can be taken at home to treat a fresh case of COVID-19. The U.S. Food and Drug Administration on Thursday approved the emergency use of the molnupiravir pill from Merck for the treatment of mild-to-moderate COVID-19 in people who have just tested positive.

Get up-to-the-minute news sent straight to your device.

Topics

Trending

Breaking News